Holen Sie sich die Stockscreener-App
27.94
1.41%
-0.40
Handel nachbörslich:
27.67
-0.27
-0.97%
Structure Therapeutics Inc Adr Aktie (GPCR) Neueste Nachrichten
Morningstar Mobile - Morningstar
Short Interest in Structure Therapeutics Inc. (NASDAQ:GPCR) Rises By 5.8% - MarketBeat
2 Companies Poised to Capitalize on the Rise of GLP-1 Drugs - Morningstar
Novo’s Ozempic, Wegovy Targeted for Medicare Price Cuts - BNN Bloomberg
GAMMA Investing LLC Raises Stock Position in Structure Therapeutics Inc. (NASDAQ:GPCR) - Defense World
Schrödinger Secures $150M Novartis Deal, Advances Three Clinical Programs for 2025 - StockTitan
Analysts Set Structure Therapeutics Inc. (NASDAQ:GPCR) PT at $81.29 - Defense World
Structure Therapeutics (NASDAQ:GPCR) Hits New 1-Year LowShould You Sell? - MarketBeat
Stifel Nicolaus Begins Coverage on Structure Therapeutics (NASDAQ:GPCR) - Defense World
Structure Therapeutics Inc. (NASDAQ:GPCR) Receives Average Recommendation of "Buy" from Analysts - MarketBeat
Stock Market Movers Today • Top Gainers & Losers - Benzinga
Structure Therapeutics (NASDAQ:GPCR) Shares Gap UpHere's What Happened - MarketBeat
Stifel analysts initiate Structure Therapeutics stock with buy rating By Investing.com - Investing.com Canada
State Street Corp Increases Holdings in Structure Therapeutics Inc. (NASDAQ:GPCR) - Defense World
Structure Therapeutics (NASDAQ:GPCR) Reaches New 1-Year LowShould You Sell? - MarketBeat
Structure Therapeutics (NASDAQ:GPCR) Stock Price Down 5.5%Here's Why - MarketBeat
Structure Therapeutics (NASDAQ:GPCR) Trading 5.6% HigherStill a Buy? - MarketBeat
Structure Therapeutics Inc. (NASDAQ:GPCR) Shares Purchased by Principal Financial Group Inc. - MarketBeat
Barclays PLC Boosts Position in Structure Therapeutics Inc. (NASDAQ:GPCR) - MarketBeat
Structure Therapeutics (NASDAQ:GPCR) Shares Gap Up – Time to Buy? - Defense World
Structure Therapeutics (NASDAQ:GPCR) Shares Up 6.6%Still a Buy? - MarketBeat
Structure Therapeutics (NASDAQ:GPCR) Earns "Buy" Rating from HC Wainwright - MarketBeat
Franklin Resources Inc. Boosts Stake in Structure Therapeutics Inc. (NASDAQ:GPCR) - MarketBeat
Structure Therapeutics' SWOT analysis: oral obesity drug stock shows promise amid fierce competition - Investing.com
Here's Why VKTX Stock Plummeted 18% on Wednesday - Yahoo Finance
Merck moves into obesity with deal for Hansoh’s GLP-1 pill - BioPharma Dive
Structure Therapeutics (NASDAQ:GPCR) Sets New 1-Year LowWhat's Next? - MarketBeat
Structure Therapeutics (NASDAQ:GPCR) Earns Market Outperform Rating from JMP Securities - MarketBeat
Structure Therapeutics Inc. (NASDAQ:GPCR) Short Interest Update - Defense World
Structure Therapeutics Selects Lead Oral Small Molecule for Obesity Treatment - Defense World
Structure Therapeutics Inc. (NASDAQ:GPCR) Receives $85.67 Consensus PT from Brokerages - Defense World
Structure Therapeutics Advances Obesity Treatment Candidate - TipRanks
Structure Therapeutics Unveils Breakthrough Oral Obesity Drug, First-in-Class Amylin Agonist Shows Promise - StockTitan
Mcewen Mining Inc (MUX-N) QuotePress Release - The Globe and Mail
Structure Therapeutics' SWOT analysis: oral GLP-1 stock faces fierce competition - Investing.com
Market Factors: The biggest debatesand risksfor investors looking to outperform in 2025 - The Globe and Mail
Structure Therapeutics Inc. (NASDAQ:GPCR) Receives $85.67 Average PT from Analysts - MarketBeat
Exome Asset Management LLC Makes New $5.27 Million Investment in Structure Therapeutics Inc. (NASDAQ:GPCR) - MarketBeat
Structure Therapeutics Inc (GPCR-Q) QuotePress Release - The Globe and Mail
2 ‘Monster’ Stocks To Snap Up Before 2025 - Barchart
Y Intercept Hong Kong Ltd Makes New $1.79 Million Investment in Structure Therapeutics Inc. (NASDAQ:GPCR) - MarketBeat
Pier Capital LLC Buys 33,087 Shares of Structure Therapeutics Inc. (NASDAQ:GPCR) - MarketBeat
Wellington Management Group LLP Purchases 221,851 Shares of Structure Therapeutics Inc. (NASDAQ:GPCR) - MarketBeat
Structure Therapeutics (NASDAQ:GPCR) Shares Gap Up – Here’s Why - Defense World
FY2024 Earnings Estimate for GPCR Issued By Leerink Partnrs - Defense World
Brokers Offer Predictions for GPCR FY2024 Earnings - MarketBeat
Leerink Partnrs Has Bearish Outlook for GPCR FY2025 Earnings - Defense World
Bank of Montreal Can Has $1.94 Million Position in Structure Therapeutics Inc. (NASDAQ:GPCR) - MarketBeat
Structure Therapeutics' SWOT analysis: oral GLP-1 stock shows promise amid fierce competition By Investing.com - Investing.com South Africa
84,000 Shares in Structure Therapeutics Inc. (NASDAQ:GPCR) Acquired by Readystate Asset Management LP - MarketBeat
Point72 Asset Management L.P. Purchases 820,589 Shares of Structure Therapeutics Inc. (NASDAQ:GPCR) - MarketBeat
Structure Therapeutics' SWOT analysis: oral GLP-1 stock shows promise amid fierce competition - Investing.com India
1.44%
7.27%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):